Loading...
Loading...
SILK| Name | Value |
|---|---|
| Revenues | 48.5M |
| Cost of Revenue | 12.0M |
| Gross Profit | 36.5M |
| Operating Expense | 51.4M |
| Operating I/L | -14.9M |
| Other Income/Expense | 0.8M |
| Interest Income | 2.5M |
| Pretax | -14.1M |
| Income Tax Expense | 0.9M |
| Net Income/Loss | -14.1M |
Silk Road Medical, Inc. specializes in medical devices for treating carotid artery disease, offering the ENROUTE Transcarotid Neuroprotection System for temporary blood flow reversal, the ENROUTE Transcarotid Stent System, the ENHANCE Transcarotid Peripheral Access Kit, and the ENROUTE 0.014 Guidewire for interventional device delivery. These products enable the company to generate revenue by providing innovative solutions for transcarotid artery revascularization, catering to the needs of patients and healthcare professionals in the United States.
